Therapeutic uspa1-derived peptides
CA 2500960 A1 · Owner: University Of Bristol · Inventors: Virji, Mumtaz
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a ligand isolated from Moraxella catarrhalis outer membrane protein which binds to CEACAM receptors said ligand comprising , a receptor binding domain comprising an amino acid sequence selected from the group disclosed, or a fragment, homologue functional equivalent, derivative, degenerate or hydroxylation sulphonation or glycosylation product or other secondary processing product thereof. The invention also provides medicaments and vaccines comprising said ligand, and their use in the treatment or prophylaxis of infection. Also provided is a screening method for the identification of novel therapeutic compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 1, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 1, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 1, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.